Ledger. Australian venture funding, tracked

3052 rounds · 1931 startups · 3553 investors

Key

Person Invested in this round Raised it Closed a fund Mentioned

Amount confirmed Amount is an estimate


Grant

Allergan to Acquire Elastagen to Access Next Generation Injectable Portfolio

Sydney-based tropoelastin biotech Elastagen agreed to an Allergan takeover offering US$95 million upfront plus contingent payments; the GBS Ventures-backed company previously drew MDF and federal grant funding.

Also GBS Ventures

Unnamed stage $1m

2017: the year agtech hit the mainstream

A year-end reflection on Australian agtech's 2017 rise, covering FluroSat's investment round, several startups' funding totals, SproutX's first accelerator cohort, Observant's acquisition, and the author's hopes for 2018.

Also Tenacious Ventures portfolio·Cotton Research and Development Corporation

2 deals

Shippit rejects $5M and secures a strategic $2.2M Series A

Shipping platform Shippit took a AU$2.2 million Series A led by Aura Group, with Addventure Fund and RTL Group participating, turning down a larger oversubscribed offer to bankroll Asia-Pacific expansion and hiring.

Also Startup Daily

Series B $14m

Cell Innovation Partners, Japanese venture group, invests in Elastagen as part of a Second Close to the Series B Equity Financing.

Cell Innovation Partners invested A$1 million in Sydney biotech Elastagen within a second close of its A$14 million Series B, with AMOREPACIFIC Ventures, Korea Investment Partners and the Wellcome Trust also joining the round.

2 deals

Uniseed invests $1m in PERKii's $4m funding round

Venture fund Uniseed led a million-dollar slice of probiotic drinks maker PERKii's four-million-dollar round, its first deal from its new $50 million fund, to fund a national launch.

Also Startup Daily

Showing 6201–6250 of 6451 ·